ENT Masthead
September 2013
  You're Invited!
Songs for Sound presents:

the 
hEAR the MUSIC Tour

Supporting MUSC's Cochlear Implant Program

  In This Issue 

HPV Negative and HPV Positive Oropharyngeal Carcinomas
About Dr. Hornig

  Upcoming E-Updates 

October:
Environmental Control Measures for House Dust Mite Allergy. What is the Evidence?

November:
Hypoglossal Nerve Stimulation for Sleep Apnea

December:
Management of Acute and Chronic Nasal Fractures

  E-Updates  Archives 

Our E-Update Newsletters are designed to provide brief, practical, clinical updates in areas where we all struggle in managing our patients. To view past issues, please visit our Archives.

  Quick Links  

  Continuing Education

October 2013 
Charleston Swallowing Conference

Head & Neck Oncology Sea to Summit


February 2014 
Charleston Sleep Surgery Symposium

 

March 2014 
Pediatric ENT Update

Sinus Masters

 

April 2014 
Temporal Bone Dissection Course

 

May 2014 
Southern States Rhinology Course

Charleston Magnolia Conference

July 2014 
The Charleston Course: Otolaryngology Literature Update 
 
 

 

For program brochure, registration form, and more, please visit
our website.

We want to hear from you!

We welcome your  feedback - answers, questions, input - on our newsletter articles as well as any ENT questions you may have. If there are topics you are interested in learning more about, please
Join Our Mailing List
Changing
What's
Possible

Dear Colleague,     

 

In this month's ENT E-Update Joshua A. Hornig, MD, FRCS(C) compares and contrasts HPV positive and HPV negative oropharyngeal carcimomas to assist you with timely care for your patients.

More information on Dr. Hornig follows the article below and is on our website.

Please feel free to contact us with feedback or questions about the E-Udate articles, your patients, or any other ENT issue at entupdate@musc.edu.

 

 

Paul R. Lambert, MD

Professor and Chair

Joshua Hornig surgery
Joshua D. Hornig, M.D., FRCS(C)
Director, Microvascular Surgery & Functional Outcomes
Medical University of South Carolina
HPV Positive and HPV
Negative Oropharyngeal Carcinomas

The rate of oropharyngeal carcinoma is rapidly increasing in North America in the last several decades. This increase seems to be secondary to the increased rate of HPV related orophayrngeal carcinomas and not due to a change in smoking or drinking prevalence.

 

Interestingly, the clinical presentation between HPV positive and HPV negative oropharyngeal cancers are strikingly different and can lead to a delay in diagnosis if the proper vigilance is not kept. This short article will compare and contrast the typical HPV positive and HPV negative clinical presentation to assist you in providing timely care for these patients.

 

The typical epidemiological profile of HPV-negative cancer is in the 7th decade of life, male pre-dominance (3:1 male: female ratio), strong association with tobacco and alcohol use, moderate association with poor oral hygiene, and a diet low in fruit and vegetable consumption. In contrast, HPV-positive cancer patients are characterized by a younger age of onset (6th decade of life), male predominance (3:1 male: female ration), strong associations with sexual behaviors, strong association with marijuana use and inconsistent association with tobacco and alcohol use.

 

HPV positive oropharyngeal cancer patients typically present at a more advanced clinical stage. However, their T stage is usually lower and they are increasingly likely to have nodal metastasis to the cervical lymph node groups compared to HPV-negative oropharyngeal cancers. Interestingly, there are also differences in histological features. HPV-positive cancers have distinct histological features, such as moderate/poor tumor differentiation and non-keratinizing or basaloid pathology.

 

One of the most striking differences is in the type of lymphadenopathy that develops. While in the majority of cases the HPV-positive and HPV-negative tumors are indistinguishable from each other, there are is much higher preponderance of cystic lymph nodes in patients with HPV-positive cancers. Interestingly, often the FNA of these cystic lesions can be misinterpreted by the cytopathologist as containing benign looking squamous cells. This is particularly important for the Head & Neck Surgeon as this will lead to an erroneous diagnosis of a branchial cleft cyst. The surgeon must remain hyper vigilant in these cases and ensure a thorough upper aerodigestive examination to rule out a primary. Often once the erroneously diagnosed branchial cleft cyst is removed, then the true diagnosis of squamous cell carcinoma is finally discovered.

 

Clinical Pearl:  HPV positive carcinoma will often present with a cystic neck mass that can be misdiagnosed as a benign branchial cleft cyst.

 

 

Table 1: Clinical Comparison of HPV-positive and HPV-negative Oropharyngeal carcinomas

 

 

HPV -

HPV +

Age

7th decade

6th decade

M:F ratio

3:1

3:1

Tobacco Use

Strong

Variable

Alcohol Use

Strong

Variable

Marijuana Use

Negligible

Strong

Oral Hygiene

Poor

Unknown

Fruit/Vegetable Intake

Poor

Unknown

Sexual Activity

Negligible

Strong

 

 

Joshua D. Hornig , M.D., FRCS(C)
Associate Professor; Director, Microvascular Surgery &
Functional Outcomes  
Medical University of South Carolina 
About Dr. Hornig... 
  Joshua Hornig headshot

Joshua D. Hornig , M.D., FRCS(C)

- Associate Professor
- Director, Microvascular Surgery & Functional Outcomes 
M.D.: University of Alberta
Residency: University of Alberta

Fellowship: Medical University of SC

Special interests: Endoscopic thyroid and parathyroid surgery, Robotic thyroid and oral surgery, Facial plastic surgery, Head and neck tumors  


Medical University of South Carolina Department of Otolaryngology - Head & Neck Surgery

135 Rutledge Avenue, MSC 550, Charleston, SC 29425|Phone: 843.792.8299|Website: ENT.musc.edu|� 2013